Mezzion Pharmaceuticals News and Activities

View the org chart displaying its 3 main executives

Most searched biographies at Mezzion Pharmaceuticals

• Dean Park, Chief Executive Officer
• John Presser, Executive Vice President, Chief Business Officer
• Ridwan Shabsigh, President & Chief Operating Officer

Popular executive movements at Mezzion Pharmaceuticals

• Ridwan Shabsigh has joined the company as President & Chief Operating Officer  (posted on January 7 2026).

Create your alert
to follow the executive moves at Mezzion Pharmaceuticals.

Mezzion Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Mezzion Pharmaceuticals

• Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients - PR Newswire — Mezzion
• The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation - ScienceDirect — Mezzion
• Investors & News — Mezzion
• New ICD-10 Codes Recognize Fontan-Associated Conditions, Advancing Care and Coverage for Rare Congenital Heart Disease Community - PR Newswire — Mezzion

Social media about Mezzion Pharmaceuticals

• Mezzion Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Mezzion Pharmaceuticals on LinkedIn, X (Twitter) & YouTube